Cargando…
Glycosylation Changes on Serum Glycoproteins in Ovarian Cancer May Contribute to Disease Pathogenesis
Ovarian cancer is the most lethal of all gynaecological cancers among women. Serum CA125 is the only biomarker that is used routinely and there is a need for further complementary biomarkers both in terms of sensitivity and specificity. N-glycosylation changes in ovarian cancer serum glycoproteins i...
Autores principales: | Saldova, Radka, Wormald, Mark R., Dwek, Raymond A., Rudd, Pauline M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3827796/ https://www.ncbi.nlm.nih.gov/pubmed/19126966 http://dx.doi.org/10.1155/2008/601583 |
Ejemplares similares
-
Exploring the Glycosylation of Serum CA125
por: Saldova, Radka, et al.
Publicado: (2013) -
5-AZA-dC induces epigenetic changes associated with modified glycosylation of secreted glycoproteins and increased EMT and migration in chemo-sensitive cancer cells
por: Greville, Gordon, et al.
Publicado: (2021) -
Hypoxia Alters Epigenetic and N-Glycosylation Profiles of Ovarian and Breast Cancer Cell Lines in-vitro
por: Greville, Gordon, et al.
Publicado: (2020) -
Improvement of Prostate Cancer Diagnosis by Detecting PSA Glycosylation-Specific Changes
por: Llop, Esther, et al.
Publicado: (2016) -
Improvement of Prostate Cancer Diagnosis by Detecting PSA Glycosylation-Specific Changes: Erratum
por: Llop, Esther, et al.
Publicado: (2018)